Literature DB >> 811658

Studies on thyroid hormone-binding proteins. II. Binding of thyroid hormones, retinol-binding protein, and fluorescent probes to prealbumin and effects of thyroxine on prealbumin subunit self association.

S F Nilsson, L Rask, P A Peterson.   

Abstract

Vitamin A in human plasma is transported by its specific carrier protein, the retinol-binding protein. Under physiological conditions the protein forms a stable protein-protein complex with the tetrameric plasma protein, the thyroxine-binding prealbumin. Human prealbumin was shown to interact with the fluorescent probes 1,8-anilinonaphthalene sulfonate (ANS) and 2-p-toluidinylnaphthalene-6-sulfonate (TNS). ANS bound to the protein at two independent sites with the apparent association constant 3 X 10(5) M-1, whereas TNS interacted with a single site with the binding constant 5 X 10(k) M-1. The fluorescent yield of protein-bound ANS was 0.95, a more than 200-fold enhancement compared with that of ANS in aqueous solutions. TNS enhanced its quantum yield nearly 500-fold to 0.37. On addition of thyroid hormones the fluorescent probes could be quantitatively displaced from the protein. This finding suggested that triiodthyronine, thyroxine, and the probes bound to a common site in prealbumin, which is likely to have a strongly hydrophobic character. The association constants for the interaction between prealbumin and the thyroid hormones could be calculated by using the hormones as competitive inhibitors in the TNS-prealbumin titrations. The data from the competition experiments together with those obtained from equilibrium dialysis revealed one major hormone binding site on the protein. The calculated association constant were 9 X 10(6) M-1 and 1 X 10(8) M-1 for triiodothyronine and thyroxine, respectively. Prealbumin monomers were bound to Sepharose by covalent attachment, and their properties were examined. Evidence was obtained demonstrating that the retinol-binding protein could interact with a single subunit of prealbumin. The estimated apparent association constant for the interaction of the protein and the matrix-bound monomeric prealbumin was 3 X 10(4) M-1, approximately 250-fold lower than that measured for protein and matrix-bound tetrameric prealbumin. The data, however, strongly suggest that there are four retinol-binding protein sites per prealbumin molecule. Using the technique of sedimentation equilibrium ultracentrifugation the prealbumin subunit self-association has been studied. The energy of the interaction for the prealbumin subunits is very high, and various concentrations of guanidine hydrochloride has to be used to perturb the equilibrium. All experiments indicated that prealbumin dissociates directly into monomers without the presence of intermediate forms. Thyroxine perturbed the chemical equilibrium of the prealbumin monomer-tetramer system by strengthening the interaction between the subunits.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 811658

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Inhibition of curli assembly and Escherichia coli biofilm formation by the human systemic amyloid precursor transthyretin.

Authors:  Neha Jain; Jörgen Ådén; Kanna Nagamatsu; Margery L Evans; Xinyi Li; Brennan McMichael; Magdalena I Ivanova; Fredrik Almqvist; Joel N Buxbaum; Matthew R Chapman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-30       Impact factor: 11.205

2.  Assessment of the effects of transthyretin peptide inhibitors in Drosophila models of neuropathic ATTR.

Authors:  Lorena Saelices; Malgorzata Pokrzywa; Katarzyna Pawelek; David S Eisenberg
Journal:  Neurobiol Dis       Date:  2018-09-10       Impact factor: 5.996

3.  Inhibiting transthyretin conformational changes that lead to amyloid fibril formation.

Authors:  S A Peterson; T Klabunde; H A Lashuel; H Purkey; J C Sacchettini; J W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

4.  Support for the multigenic hypothesis of amyloidosis: the binding stoichiometry of retinol-binding protein, vitamin A, and thyroid hormone influences transthyretin amyloidogenicity in vitro.

Authors:  J T White; J W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

5.  Description of the quaternary structure of tetrameric proteins. Forms that show either right-handed or left-handed symmetry at the subunit level.

Authors:  E J Milner-White
Journal:  Biochem J       Date:  1980-05-01       Impact factor: 3.857

6.  Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy.

Authors:  Mikael Lindgren; Karin Sörgjerd; Per Hammarström
Journal:  Biophys J       Date:  2005-03-11       Impact factor: 4.033

7.  Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis.

Authors:  Nora S Green; Ted R Foss; Jeffery W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-29       Impact factor: 11.205

8.  Why is Leu55-->Pro55 transthyretin variant the most amyloidogenic: insights from molecular dynamics simulations of transthyretin monomers.

Authors:  Mingfeng Yang; Ming Lei; Shuanghong Huo
Journal:  Protein Sci       Date:  2003-06       Impact factor: 6.725

9.  Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors.

Authors:  Teresa Mairal; Joan Nieto; Marta Pinto; Maria Rosário Almeida; Luis Gales; Alfredo Ballesteros; José Barluenga; Juan J Pérez; Jesús T Vázquez; Nuria B Centeno; Maria Joao Saraiva; Ana M Damas; Antoni Planas; Gemma Arsequell; Gregorio Valencia
Journal:  PLoS One       Date:  2009-01-06       Impact factor: 3.240

10.  Novel transthyretin amyloid fibril formation inhibitors: synthesis, biological evaluation, and X-ray structural analysis.

Authors:  Satheesh K Palaninathan; Nilofar N Mohamedmohaideen; Elisabetta Orlandini; Gabriella Ortore; Susanna Nencetti; Annalina Lapucci; Armando Rossello; Joel S Freundlich; James C Sacchettini
Journal:  PLoS One       Date:  2009-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.